Company intelligence / Profile preview

SynBalance

Ownership: Private
Employees: ~20
Development stage: Commercial

Overview

Clinically tested proprietary probiotic strains with evidence supporting immune function improvement, women’s urogenital health benefits (reduction of BV relapses), oral care benefits, and mood modulation. Products have won NutraIngredients Awards Europe in multiple years.

Therapeutic areas: OtherPsychiatryInfectious Diseases
Modalities: Probiotic bacteria (live and inactivated)synbiotics
Industry: Non-Drug Biotech

Drug pipeline

1 asset

KeepCalm

Commercial

Indications: Stress, Anxiety, Sleep disorders, Post-partum mental health

Partnerships

Works closely with ROELMI HPC group and collaborates widely within the nutraceutical industry for ingredient supply and licensing

Beyond the preview

Go deeper on SynBalance.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SynBalance.

Explore the full profile